Dr. Frank Porreca’s research into kappa opioid receptors may lead to a therapeutic option for people who have chronic pain and trouble sleeping.

In an unexpected reversal, an FDA advisory committee voted 7-2 on Wednesday to support approval of AMX0035, an investigational drug being evaluated for amyotrophic lateral sclerosis.

Gary Nabhan, PhD, research social scientist in the College of Social and Behavioral Sciences, is designing a study with collaborators at the Andrew Weil Center for Integrative Medicine in the College of Medicine – Tucson, including research director Esther Sternberg, MD, professor of medicine in the College of Medicine – Tucson, to quantify the health effects before, during and after experiences in the desert.

A downtown Phoenix building was designed to mitigate the effects of unforgiving summer temperatures.

The new round of COVID-19 booster shots, reformulated to target the BA.4 and BA.5 omicron subvariants as well as the original strain of COVID, are the first shots to be distributed prior to human trials.

Recent research suggests that people who work out have stronger resistance to infectious diseases, including COVID-19, but experts say the findings need to be tested further. Richard Simpson, PhD, professor in the UArizona College of Agriculture and Life Sciences with appointments in the College of Medicine – Tucson, is quoted.

An increasing number of vaccine deniers coupled with one of the easiest opt-out provisions in the nation has left Arizona with close to 1 out of every 10 kindergartners unprotected against key childhood diseases.

A study led by researchers at the University of Arizona Health Sciences discovered new information about the inner workings of the immune system that could have a profound impact on T cell therapies for cancer and other diseases.